The diagnostic modalities, stratification tools, and treatment options for patients with thyroid
cancer have rapidly evolved since the development of the American Thyroid Association …

Thyroid cancer is the most prevalent endocrine malignancy that comprises mostly indolent
differentiated cancers (DTCs) and less frequently aggressive poorly differentiated (PDTC) or …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Background: One of the most widely used risk stratification systems for estimating individual
patients' risk of persistent or recurrent differentiated thyroid cancer (DTC) is the American …

Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

The incidence of papillary thyroid microcarcinoma (microPTC) has dramatically increased in
the last decades. Most of these tumors remain small and clinically “silent”, only small number …

Context The risk stratification of patients with differentiated thyroid cancer (DTC) is crucial in
clinical decision making. The most widely accepted method to assess risk of …

Purpose Aim of this study was to evaluate the association between body mass index (BMI)
and aggressive features of differentiated thyroid cancer (DTC) in a prospective cohort …

Thyroid cancers developed from the tissues of the thyroid gland are classified into papillary
(PTC), follicular (FTC), medullary (MTC), and anaplastic thyroid cancer (ATC). Although …

Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …